Your browser doesn't support javascript.
loading
Formation of the IGF1R/CAV1/SRC tri-complex antagonizes TRAIL-induced apoptosis in gastric cancer cells.
Guo, Tianshu; Xu, Ling; Che, Xiaofang; Zhang, Simeng; Li, Ce; Wang, Jin; Gong, Jing; Ma, Rui; Fan, Yibo; Hou, Kezuo; Zhou, Huiming; Hu, Xuejun; Liu, Yunpeng; Qu, Xiujuan.
Affiliation
  • Guo T; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Xu L; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Che X; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Zhang S; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Li C; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Wang J; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Gong J; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Ma R; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Fan Y; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Hou K; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Zhou H; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Hu X; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Liu Y; Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, 110001, China.
  • Qu X; Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University, Shenyang, 110001, China.
Cell Biol Int ; 41(7): 749-760, 2017 Jul.
Article in En | MEDLINE | ID: mdl-28403518
ABSTRACT
Lipid rafts provide a biological platform for apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). We previously reported that insulin-like growth factor 1 receptor (IGF1R) translocation into lipid rafts helped to explain TRAIL resistance. However, it was not clear whether TRAIL resistance was caused by the interaction of IGF1R with caveolin-1 (CAV1) and the non-receptor tyrosine kinase SRC in lipid rafts of gastric cancer cells. Here, we observed high IGF1R expression in TRAIL-resistant gastric cancer cells, and showed that IGF1R combined with both CAV1 and SRC in a native complex. TRAIL was shown to promote the formation of the IGF1R/CAV1/SRC tri-complex and the activation of these three molecules. Knockdown of IGF1R or CAV1 or inhibition of SRC activity reduced the formation of this tri-complex and enhanced TRAIL-induced apoptosis. Furthermore, the overexpression of microRNA-194 reversed TRAIL resistance by reducing IGF1R expression. In summary, TRAIL increased formation of the IGF1R/CAV1/SRC tri-complex and the activation of downstream survival pathways, leading to TRAIL resistance in gastric cancer cells.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Receptors, Somatomedin / Apoptosis / Src-Family Kinases / Caveolin 1 / TNF-Related Apoptosis-Inducing Ligand Limits: Humans Language: En Journal: Cell Biol Int Year: 2017 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Main subject: Stomach Neoplasms / Receptors, Somatomedin / Apoptosis / Src-Family Kinases / Caveolin 1 / TNF-Related Apoptosis-Inducing Ligand Limits: Humans Language: En Journal: Cell Biol Int Year: 2017 Type: Article Affiliation country: China